Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LITHIUM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | LITHIUM |
| Key Genes/Proteins | AKT, ALPHA-SYNUCLEIN, AMPK, AMYLOID, AMYLOID-BETA, APP |
| Related Diseases | AGING, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, APOPTOSIS, AUTOPHAGY |
graph TD
LITHIUM["LITHIUM"]
LITHIUM -->|"treats"| bipolar_disorder["bipolar disorder"]
LITHIUM -->|"inhibits"| dopamine_synthesis["dopamine synthesis"]
LITHIUM -->|"enhances"| AUTOPHAGY["AUTOPHAGY"]
LITHIUM -->|"expressed in"| Brain["Brain"]
LITHIUM -->|"activates"| MAPK_signaling["MAPK signaling"]
LITHIUM -->|"upregulates"| BETA_CATENIN["BETA-CATENIN"]
LITHIUM -->|"modulates"| BDNF["BDNF"]
AUTOPHAGY -->|"promotes"| LITHIUM
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"depletes"| LITHIUM
ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"activates"| LITHIUM| Target | Relation | Type | Str |
|---|---|---|---|
| Bdnf/Trkb/Akt/Gsk-3Β/Mtor/Nrf2/Ho-1 Axis | modulates | pathway | 0.95 |
| bipolar disorder | treats | disease | 0.90 |
| Chemotherapy-Induced Depression | treats | disease | 0.90 |
| dopamine synthesis | inhibits | process | 0.85 |
| Chemobrain | treats | disease | 0.85 |
| DEPRESSION | treats | disease | 0.80 |
| MAPK signaling | activates | pathway | 0.80 |
| GSK3B | inhibits | gene | 0.80 |
| Depression | treats | disease | 0.80 |
| Brain | expressed_in | cell_type | 0.80 |
| GSK-3β | inhibits | protein | 0.80 |
| CHEMOBRAIN | treats | disease | 0.80 |
| STS | targets | gene | 0.80 |
| BDNF | modulates | protein | 0.75 |
| epilepsy | treats | disease | 0.70 |
| depression | treats | disease | 0.70 |
| APOPTOSIS | protects_against | phenotype | 0.70 |
| APOPTOSIS | activates | phenotype | 0.70 |
| BDNF | activates | gene | 0.65 |
| AUTOPHAGY | protects_against | phenotype | 0.65 |
| BDNF | inhibits | gene | 0.65 |
| NEURODEGENERATION | inhibits | disease | 0.65 |
| NEURODEGENERATION | activates | disease | 0.65 |
| SENESCENCE | inhibits | phenotype | 0.65 |
| AMYLOID | protects_against | protein | 0.65 |
| DEPRESSION | inhibits | disease | 0.65 |
| DEPRESSION | activates | disease | 0.65 |
| BMAL1 | interacts_with | gene | 0.60 |
| neurodegeneration | treats | disease | 0.60 |
| diabetes | treats | disease | 0.60 |
| ALS | treats | disease | 0.60 |
| ferroptosis | modulates | pathway | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| neuroinflammation | treats | disease | 0.60 |
| HDAC6 | targets | gene | 0.60 |
| BMAL1 | targets | gene | 0.60 |
| REV | targets | gene | 0.60 |
| Alzheimer's disease | treats | disease | 0.60 |
| PER1 | targets | gene | 0.60 |
| BMAL1 | regulates | gene | 0.60 |
| Parkinson's disease | treats | disease | 0.60 |
| PARKINSON'S DISEASE | associated_with | disease | 0.55 |
| AGING | associated_with | phenotype | 0.55 |
| neurotrophin signaling | modulates | pathway | 0.55 |
| APP | targets | gene | 0.55 |
| BDNF | targets | gene | 0.55 |
| Wnt signaling | modulates | pathway | 0.55 |
| PS1 | targets | gene | 0.55 |
| PI3K | associated_with | gene | 0.50 |
| NEURONS | associated_with | cell_type | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURONS | interacts_with | cell_type | 0.70 |
| APOPTOSIS | associated_with | phenotype | 0.50 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.50 |
| DIABETES | associated_with | disease | 0.50 |
| TAU PHOSPHORYLATION | associated_with | phenotype | 0.50 |
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| CELL SURVIVAL | associated_with | phenotype | 0.50 |
| FERROPTOSIS | associated_with | phenotype | 0.50 |
| FIBROBLASTS | associated_with | cell_type | 0.50 |
| WNT SIGNALING | associated_with | pathway | 0.50 |
| BIPOLAR DISORDER | associated_with | disease | 0.50 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| NEUROFIBRILLARY TANGLES | associated_with | phenotype | 0.45 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
| MELANOMA | associated_with | disease | 0.45 |
| EPILEPSY | associated_with | disease | 0.45 |
| SENESCENCE | associated_with | phenotype | 0.45 |
| VALPROIC ACID | associated_with | drug | 0.45 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| AMYLOID-BETA | associated_with | protein | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| DEPRESSION | associated_with | disease | 0.45 |
| TIDEGLUSIB | associated_with | drug | 0.45 |
| AUTOPHAGY | activates | process | 0.35 |
| ALPHA-SYNUCLEIN | activates | gene | 0.35 |
| ALZHEIMER'S DISEASE | depletes | disease | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning LITHIUM in their description or question text
No additional research found